Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | CRYAB | P02511 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PTGES | O14684 | 4/20 | 0.79 |
| ▸ | FNTA | P49354 | 1/20 | 0.74 |
| ▸ | FNTB | P49356 | 1/20 | 0.74 |
| ▸ | CRYAA | P02489 | 1/20 | 0.71 |
| ▸ | ACHE | P22303 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.61 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.61 |
| ▸ | HMGCR | P04035 | 1/20 | 0.61 |
| ▸ | PREP | P48147 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lanosterol SCHEMBL16994483 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL145834 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL14240642 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL14536063 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL14360758 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL2154745 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL145835 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL1696473 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL19194030 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL21348006 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| EP-2323666-B1 | PHARMACEUTICAL USES OF LANOSTA-8,24-DIEN-3-OLS | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2017-01-04 | — | — | EP | claimed |
| EP-2523663-A1 | PHARMACEUTICAL USE OF MULTICYCLIC COMPOUNDS AS ANTI-AIDS AGENTS | Amazonia Fitomedicamentos Ltda (BR) | 2012-11-21 | — | — | EP | claimed |
| US-20120289487-A1 | Pharmaceutical Use of Multicyclic Compounds as Anti-Aids Agents | AMAZÔNIA FITOMEDICAMENTOS LTDA (BR) | 2012-11-15 | — | — | US | claimed |
| JP-2011529956-A | — | — | 2011-12-15 | — | — | JP | claimed |
| WO-2011086424-A1 | PHARMACEUTICAL USE OF MULTICYCLIC COMPOUNDS MIXTURES AS CONCOMITANT ANTI-CANCER, ANTI-INFLAMMATORY AND ANTI-PAIN AGENTS | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2011-07-21 | — | — | WO | claimed |
| WO-2011086423-A1 | PHARMACEUTICAL USE OF MULTICYCLIC COMPOUNDS AS ANTI-AIDS AGENTS | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2011-07-21 | — | — | WO | claimed |
| US-20110136773-A1 | Pharmaceutical Uses of Lanosta-8,24-dien-3-ols | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2011-06-09 | — | — | US | claimed |
| EP-2323666-A1 | PHARMACEUTICAL USES OF LANOSTA-8,24-DIEN-3-OLS | Amazonia Fitomedicamentos Ltda (BR) | 2011-05-25 | — | — | EP | claimed |
| WO-2010015874-A1 | PHARMACEUTICAL USES OF LANOSTA-8,24-DIEN-3-OLS | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2010-02-11 | — | — | WO | claimed |
| EP-4615821-A1 | PARTICLE COMPOSITIONS COMPRISING POLYSARCOSINE LIPID CONJUGATES | Calusa Bio, LLC (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250161327-A1 | PREPARATION OF NOVEL TRITERPENE ALCOHOL DERIVATIVES WITH ENHANCED BIOAVAILABILITY FOR CANCER, INFLAMMATION AND PAIN TREATMENT | LIVFUL INC. | 2025-05-22 | — | — | US | disclosed |
| US-20250161327-A1 | PREPARATION OF NOVEL TRITERPENE ALCOHOL DERIVATIVES WITH ENHANCED BIOAVAILABILITY FOR CANCER, INFLAMMATION AND PAIN TREATMENT | LIVFUL INC. | 2025-05-22 | — | — | US | disclosed |
| WO-2025064408-A1 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE | THE BROAD INSTITUTE, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| EP-4476236-A1 | PREPARATION OF NOVEL TRITERPENE ALCOHOL DERIVATIVES WITH ENHANCED BIOAVAILABILITY FOR CANCER, INFLAMMATION AND PAIN TREATMENT | Livful Inc (US) | 2024-12-18 | — | — | EP | disclosed |
| EP-2219587-A1 | STEROL-MODIFIED AMPHIPHILIC LIPIDS | The Regents of the University of California (US) | 2010-08-25 | — | — | EP | disclosed |
| WO-2010015875-A1 | PROCESS FOR THE PREPARATION OF LANOSTA-8-ENE COMPOU | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2010-02-11 | — | — | WO | disclosed |
| WO-2010015874-A1 | PHARMACEUTICAL USES OF LANOSTA-8,24-DIEN-3-OLS | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2010-02-11 | — | — | WO | disclosed |
| WO-2010015874-A1 | PHARMACEUTICAL USES OF LANOSTA-8,24-DIEN-3-OLS | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2010-02-11 | — | — | WO | disclosed |
| WO-2009064696-A1 | STEROL-MODIFIED AMPHIPHILIC LIPIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161327-A1 | PREPARATION OF NOVEL TRITERPENE ALCOHOL DERIVATIVES WITH ENHANCED BIOAVAILABILITY FOR CANCER, INFLAMMATION AND PAIN TREATMENT | PRKCA, DGKA, MAP3K14 | MAPT 2317/4885USP2 4700/4885ALDH1A1 3779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.